oncology – The Milli Chronicle

Saturday, May 2, 2026

Latest:

Factual Version of a Story

Featured Top Stories

NewsDesk MC May 1, 2026 Cancer Remission, Cancer Research, Cancer Treatment, CAR T Cell Therapy, clinical trials, Colon Cancer, Dostarlimab, Francis Crick Institute, Immune Checkpoint Inhibitors, immunotherapy, Jennifer Wargo, Karen Knudsen, MD Anderson Cancer Center, medical research, Memorial Sloan Kettering, Oesophageal Cancer, oncology, Oncology Innovation, Parker Institute, Personalized Medicine, Samra Turajlic, Sandra Demaria, Tumour Biology, Weill Cornell Medical Center

Immunotherapy Reshapes Cancer Care as New Trials Deliver Surgery-Free Remission

“We’re no longer only treating the tumour — in many cases, we are learning how to help the immune system

Asia Latest News Top Stories

NewsDesk MC April 27, 2026April 27, 2026 $11.75 billion deal, biosimilars, branded drugs, corporate acquisition, dermatology, emerging markets, global healthcare, healthcare business, India pharma deal, Indian pharmaceutical industry, mergers and acquisitions, Mumbai, obesity drugs, oncology, Organon, pharma expansion, pharmaceutical acquisition, specialty medicines, Sun Pharma, U.S. drugmaker, Women’s Health

Sun Pharma Strikes $11.75 Billion Organon Deal in India’s Biggest Pharma Acquisition

Mumbai — Sun Pharmaceutical Industries will acquire U.S.-based drugmaker Organon & Co in an all-cash deal valued at about $11.75